OM
Opaleye Management Inc. sold $4.8M of ETON stock
Opaleye Management Inc., 10% owner of Eton Pharmaceuticals, Inc. (ETON), sold 126,685 shares of ETON stock worth $4.8M, per an SEC Form 4 filed Jul 7, 2026.
It was an open-market sale.
The trade happened on Jul 2, 2026, 5 days before it was made public.
ETON has moved +70.5% since the trade date, from $37.50 to $63.93 (Nov 13, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filing delay
- 5 days
- Price since
- +70.5%
- Role
- 10% owner
- Source
- SEC Form 4